BD-UCL New Diagnostic test of Breast and Ovarian Cancer

BD-UCL New Diagnostic test of Breast and Ovarian Cancer

BD-UCL New Diagnostic test of Breast and Ovarian Cancer

Becton,Dickinson and company,BD and UCL business announced an agreement for improving the early detection system for breast cancers and ovarian cancers so that early and effective treatment can be provided to the patients.

BD-UCL New Diagnostic test of Breast Cancer

Breast cancer and ovarian cancer are the two most deadly cancers for women in which breast cancer is the second main cause of women death by cancer. Breast cancer is also a common cancer in women. According to most recent 2007 statistics of 

Ovarian Cancer pain

Around 204,000 cases of ovarian cancer are diagnosed annually worldwide and it is estimated that 125,000 women may die annually with this cancer. In United States and United Kingdom, ovarian cancer becomes fifth and fourth major death causing dieses in women, respectively.
This venture gives exclusive access to UCL’s “biobank” which contains more than 200,000 patient samples collected by prospective screeningclinical trials for detection of breast and ovarian cancer. BD will use these samples to develop new .....